Items tagged with Pediatrics
India: 9% children suffering from TB resistant to key drug: Study (post)
CHENNAI: From two deaths every three minutes to having the highest tuberculosis burden in the world, most surveys related to TB in India throw a startling number. And here is one more: Close to 9% of all paediatric tuberculosis patients are resistant to rifampicin, one of the first-line drugs used in the treatment of the infectious disease. This is 6% more than what was previously estimated, a study covering four metros in the country has found.
India: GeneXpert is now available free of cost for pediatric TB patients in Delhi, Chennai, Hyderabad and Kolkata (post)
Any pediatrician both in public and private sector in Delhi, Chennai, Hyderabad and Kolkata can send pediatric (pulmonary and extrapulmonary) samples to one of the laboratories listed below, and get a GeneXpert TB test done free of cost. The specimen will be tested on the same day and the results communicated to the referring provider electronically (e-mail and SMS) and at the same time notified to the Revised National Tuberculosis Programme (RNTCP) under Nikshay.
IJTLD December 2015 Supplement now online: Improving access to better TB treatment for children (post)
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Pharmacokinetics of lopinavir/ritonavir super-boosting in infants and young children co-infected with HIV and TB (post)
Lopinavir/ritonavir (LPV/r) dosed at 1:1 ratio in the presence of rifampicin (RIF) was not inferior to LPV/r 4:1 ratio without rifampicin in HIV positive children in an interim pharmacokinetics (PK) analysis presented at the 7th International Workshop on HIV Paediatrics.
NIH earmarks $2 million for pediatric TB biomarker research (post)
The National Institutes of Health announced that it aims to award $2 million in grant funding in fiscal year 2017 for research around new biomarkers to diagnose active pulmonary tuberculosis (TB) in children, including those infected with HIV.
Studies: Progress against TB hindered by faltering response to disease among key affected populations (post)
A series of new studies on TB among incarcerated persons, bovine strains of TB found in cattle that are transmitting to humans, and TB in children show that key affected populations are facing unique risks. These risks must be addressed in order to end TB by 2035, as called for by the World Health Organization’s End TB Strategy. The studies are being presented at the 46th Union World Conference on Lung Health in Cape Town, South Africa.
Lucica Ditiu: Do not delay rollout of child-friendly TB drugs (post)
Click here to watch a video interview with Dr Lucica Ditiu, Executive Director of Stop TB Partnership given at the 46th Union World Conference on Lung Health in Cape Town, South Africa.
Performance of the interferon gamma release assays in tuberculosis disease in children five years old or less (post)
Abstract
Is chemical exposure in mothers, babies, linked to poor vaccine response? (post)
Early life exposures to toxic chemicals such as PCBs and DDT dampen an infant’s response to the tuberculosis vaccine, according to a new study from the University of Rochester Environmental Health Sciences Center.
Waking up to the realities of drug-resistant tuberculosis in children (post)
In my more than 13 years as a tuberculosis (TB) researcher and pediatrician, there is one prevailing trend that has increasingly troubled me: people, especially individuals in the U.S., like to believe that TB is no longer an important issue. This misperception is dangerous, especially when one accounts for its growing resistance to drugs and the difficulties of diagnosing and treating TB, especially in children.
Page 5 of 31 · Total posts: 0
←First 4 5 6 Last→